Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure

NCT03326843 is registered in ClinicalTrials.gov with Sobi, Inc. as lead sponsor.

NCT NCT03326843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03326843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Subjects With Thrombocytopenia Scheduled for a Surgical Procedure
Lead sponsor
Sobi, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 26, 2018
Completion date
February 25, 2019
Enrollment
4 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

thrombocytopenia